Skip to main content

Table 1 Timing of echocardiographic and biomarker assessments

From: Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate

t0 t1 t2 t3 t4
Before EPI week 1 week 4 week 7 week 10
For EPI dose other than 100 ± 30 mg/m2 every three weeks
t 0 t 1 t 2 t 3 t 4
Before EPI 1 week after reaching 100 ± 30 mg/m2 1 week after reaching 200 ± 30 mg/m2 1 week after reaching 300 ± 30 mg/m2 1 week after reaching 400 ± 30 mg/m2
  1. For EPI dose 100 ± 30 mg/m2 every three weeks.